Experience

Abivax Announces $235.8 Million IPO

October 20, 2023

Cooley advised Abivax, a clinical-stage biotech company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, on its $235.8 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Ryan Sansom
Partner, Boston
Denny Won
Partner, San Francisco
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Nyron J. Persaud
Partner, New York
Madhuri Roy
Partner, Palo Alto
Courtney Thorne
Partner, Boston
Elizabeth Anne Wright
Partner, Brussels
Xander Lee
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Kevin King
Partner, Washington, DC
Katie Kazem
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Minkyu Park
Associate, New York
Jesse Schulman
Associate, Washington, DC
Barry Kuang
Associate, Boston
Olivia Creser
Associate, New York
Peter A. Haddad
Associate, San Diego
Samuel Paullin
Associate, Chicago
Evan Leitner
Associate, New York
Rick Jantz
Associate, Los Angeles Santa Monica
Cara Buchicchio
Associate, New York
Jason Valentine
Associate, Washington, DC
Jessica Koffel
Associate, Brussels
Mor Agam
Associate, New York
Cathy Rude
Paralegal Specialist, Boston

Related Practices & Industries

NewAmsterdam Pharma – $181.6 Million Follow-on Offering

June 6, 2023

Cooley advised the underwriters in NewAmsterdam Pharma’s $181.6 million follow-on offering. NewAmsterdam is a clinical-stage biopharmaceutical company with a mission to improve care of patients with metabolic diseases where currently approved therapies have not been sufficiently successful or well tolerated. Lawyers Eric Blanchard, Div Gupta, Jean Park, Minkyu Park, Charles York, and Katie Lapidus led the Cooley team.

Related contacts

Eric Blanchard
Partner, New York
Div Gupta
Partner, New York
Jean Park
Partner, New York
Minkyu Park
Associate, New York
Charles York
Associate, New York
Katie Lapidus
Associate, Washington, DC

Related Practices & Industries

Olink Holding AB – $116.6 Million Follow-on Offering

January 18, 2023

Cooley advised the underwriters in Olink Holding AB’s $116.6 million follow-on offering. Olink is a company dedicated to working with the scientific community on accelerating proteomics across multiple disease areas to enable new discoveries and improve the lives of patients. Lawyers Eric Blanchard, Charlie Kim, Minkyu Park, Ryan Walker, Katie Lapidus, Megan Taing and Charles York led the Cooley team.

Related contacts

Eric Blanchard
Partner, New York
Charlie Kim
Partner, San Diego
Minkyu Park
Associate, New York
Katie Lapidus
Associate, Washington, DC
Charles York
Associate, New York

Related Practices & Industries

Cerevel Therapeutics – $253.8 Million Follow-on Offering and Concurrent $345.0 Million Rule 144A Convertible Notes Offering

September 2, 2022

Cooley advised the underwriters in Cerevel Therapeutics’ $253.8 million follow-on offering of 7,250,000 shares of its common stock at a public offering price of $35 per share and the initial purchasers in its $345.0 million Rule 144A convertible notes offering. Cerevel is a clinical-stage biopharmaceutical company pursuing a targeted approach to neuroscience that combines a deep understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system target receptor selective pharmacology to discover and design new therapies. Lawyers Div Gupta, Daniel Goldberg, Eric Blanchard, Mischi a Marca, Jason Savich, Minkyu Park, Amiti Rothstein, Ellie Guadiana, Matt Kong, Eric Delgado and Jordan Verrilli led the Cooley team.

Related contacts

Div Gupta
Partner, New York
Daniel I. Goldberg
Partner, New York
Eric Blanchard
Partner, New York
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Minkyu Park
Associate, New York
Amiti C. Rothstein
Associate, New York
Ellie Guadiana
Partner, Los Angeles Santa Monica
Matt Kong
Associate, San Francisco
Eric J. Delgado
Associate, New York
Kindall G. Jackson
Associate, Washington, DC

Related Practices & Industries

Verona Pharma – $150 Million Follow-on Offering

September 2, 2022

Cooley advised the underwriters in Verona Pharma’s $150 million follow-on offering of 14,260,000 American depositary shares at a public offering price of $10.50 per American depositary share. Verona is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. Lawyers Daniel Goldberg, Eric Blanchard, Div Gupta, Charlie Kim, Minkyu Park, Amiti Rothstein and Olivia Creser led the Cooley team.

Related contacts

Daniel I. Goldberg
Partner, New York
Div Gupta
Partner, New York
Eric Blanchard
Partner, New York
Charlie Kim
Partner, San Diego
Minkyu Park
Associate, New York
Amiti C. Rothstein
Associate, New York
Olivia Creser
Associate, New York
Kindall G. Jackson
Associate, Washington, DC

Related Practices & Industries

View more

Memberships & affiliations

Asian American Bar Association of NY (AABANY)